InhaTarget Therapeutics

Belgium
Bruyelle, Wallonia, Belgium, 1050

Company profile

InhaTarget Therapeutics company profile

InhaTarget Therapeutics is a spin-off company project from the University of Brussels (‘ULB’), which has received financial support from the Walloon Region (more than €500k) to (i) validate of the proof-of-concept of its chemotherapy DPI products and (ii) structure the company activities.

Business identity

Contact email
[email protected]
Phone number
+32 (0)2 650 52 54
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2018-01-01, Year

Headquarters

Postal code
1050
Country code
BE
Continent
Europe

Capital profile

Funding and company signals

Articles
2

Categories and groups

Founders and investors

No public relation records are available.